Experimental drug brincidofovir targets Hard-to-Treat lymphomas
NCT ID NCT06761677
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called brincidofovir in people with lymphoma (a type of blood cancer) that has returned or not improved after standard treatments. The trial has two parts: first, finding a safe dose in up to 18 people with various lymphomas, then testing that dose in 25 people with a rare subtype called ENKL. The goal is to see if the drug can shrink tumors and to understand its side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY ADULT T-CELL LEUKEMIA LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Institute Hospital Of JFCR
Kōtoku, Japan
-
Kyoto University Hospital
Kyoto, Japan
-
Mie University Hospital
Tsu, Japan
-
National Cancer Center Hospital
Chūōku, Japan
-
National Cancer Centre Singapore
Singapore, Singapore
-
Okayama University Hospital
Okayama, Japan
-
Queen Mary Hospital
Hong Kong, China
-
Tokyo Metropolitan Komagome Hospital
Bunkyō City, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for hard-to-treat lymphoma: experimental drug combo enters phase 3 trial
- New combo offers hope for aggressive lymphoma in diverse patients
- Experimental cocktail aims to tackle tough lymphoma
- Experimental lymphoma drug ASTX660 tested in tiny, terminated trial
- Double punch: CAR-T cells followed by antibodies may boost lymphoma remission
- New pill shows promise for Hard-to-Treat lymphoma